Calidi Biotherapeutics Reports First Quarter 2025 Financial Results and Recent Operational Highlights
Bolstered management team with hires of Chief Executive Officer and Chief Medical Officer with deep biopharmaceutical experience Announced selection of IL15-superagonist as first payload to be delivered into tumors with Calidi’s first lead candidate using …